Resolution of secondary hemophagocytic lymphohistiocytosis after treatment with the JAK1/2 inhibitor ruxolitinib

Research output: Contribution to journal › Article › peer-review

Access to Document

@article{7c404c7d1a4a4253b9351cb6e72f0689,

title = "Resolution of secondary hemophagocytic lymphohistiocytosis after treatment with the JAK1/2 inhibitor ruxolitinib",

author = "Goldsmith, {Scott R.} and {Ur Rehman}, {Sana Saif} and Shirai, {Cara L.} and Kiran Vij and DiPersio, {John F.}",

year = "2019",

month = dec,

day = "10",

doi = "10.1182/BLOODADVANCES.2019000898",

language = "English",

volume = "3",

pages = "4131--4135",

journal = "Blood Advances",

issn = "2473-9529",

number = "23",

}

TY - JOUR

T1 - Resolution of secondary hemophagocytic lymphohistiocytosis after treatment with the JAK1/2 inhibitor ruxolitinib

AU - Goldsmith, Scott R.

AU - Ur Rehman, Sana Saif

AU - Shirai, Cara L.

AU - Vij, Kiran

AU - DiPersio, John F.

PY - 2019/12/10

Y1 - 2019/12/10

UR - http://www.scopus.com/inward/record.url?scp=85083371849&partnerID=8YFLogxK

U2 - 10.1182/BLOODADVANCES.2019000898

DO - 10.1182/BLOODADVANCES.2019000898

M3 - Article

C2 - 31821455

AN - SCOPUS:85083371849

SN - 2473-9529

VL - 3

SP - 4131

EP - 4135

JO - Blood Advances

JF - Blood Advances

IS - 23

ER -